Skip to main content

Breast Cancer

Featured Article
Alison Conlin, MD, MPH, medical oncologist, explains how care for HER2+ breast cancer has changed over the last 2 to 4 years compared with other forms of breast cancer—highlighting the approval of…
William Rayford Gwin III, MD, medical oncologist, Seattle Cancer Care Alliance, breaks down some common challenges in treating breast cancer that make it unique compared to other types of cancer, and…

Insights

In this two-part series, Yvette Terrie, BS Pharm, RPh, consultant pharmacist, discusses the impact the pandemic has had on diagnosis, treatment and screening of breast cancer, latest breakthroughs in therapies, and helping patients in their journey…

Interactive Features

Alison Conlin, MD, MPH, medical oncologist, Providence Cancer Institute, stresses the importance of research in breast cancer care and says the stressors and outcomes of the pandemic share similarity to those of a cancer-related outcomes.
Alison Conlin, MD, MPH, medical oncologist, explains how care for HER2+ breast cancer has changed over the last 2 to 4 years compared with other forms of breast cancer—highlighting the approval of four new drugs and indications—and says COVID-19 has…
William Rayford Gwin III, MD, medical oncologist, Seattle Cancer Care Alliance, breaks down some common challenges in treating breast cancer that make it unique compared to other types of cancer, and provides some risk reducing strategies for breast…
Jairam Krishnamurthy, MD, FACP, assistant professor of medicine, University of Nebraska Medical Center, reviews what it is like to navigate through breast cancer care with the whole care team—including the patient, pharmacists, other providers, and…
Back to Top